Association studies of toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of north india

Clinical Transplantation

Volumn 26, Issue 4, 2012, Pages 581-588

  Srivastava, Priyanka ^a   Singh, Anugya ^a   Kesarwani, Praveen ^a   Jaiswal, Praveen K ^a   Singh, Vibha ^a   Mittal, Rama D ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Allograft rejection; Polymorphism; Toll like receptors; Transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DNA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANGRAF; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; INDIA; INNATE IMMUNITY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RECEPTOR GENE; REJECTION FREE SURVIVAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TLR2 GENE; TLR3 GENE; TLR9 GENE; TOLL LIKE RECEPTOR GENE; VASCULAR REJECTION;

ADOLESCENT; ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; SURVIVAL RATE; TISSUE DONORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 9; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84864951692     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01577.x     Document Type: Article

References (36)

1. Goldstein DR. Toll like receptors and acute allograft rejection. Transpl Immunol 2006: 17: 11.
2. Perico N, Cattaneo D, Sayegh MH et al.Delayed graft function in kidney transplantation. Lancet 2004: 364: 1814.
3. Obhrai J, Goldstein DR. The role of toll-like receptors in solid organ transplantation. Transplantation 2006: 81: 497.
4. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001: 1: 135.
5. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003: 21: 335.
6. LaRosa DF, Rahman AH, Turka LA. The innate immune system in allograft rejection and tolerance. J Immunol 2007: 178: 7503.
7. Goldstein DR, Tesar BM, Akira S et al.Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003: 111: 1571.
8. McKay D, Shigeoka A, Rubinstein M et al.Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol 2006: 36: 1994.
9. Palmer SM, Burch LH, Davis RD et al.The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 2003: 168: 628.
10. Ducloux D, Deschamps M, Yannaraki M et al.Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005: 67: 2454.
11. Kiechl S, Lorenz E, Reindl M et al.Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002: 347: 185.
12. Edfeldt K, Bennet AM, Eriksson P et al.Association of hypo-responsive Toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 2004: 25: 1447.
13. Morange PE, Tiret L, Saut N et al.TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: the PRIME Study. Eur J Hum Genet 2004: 12: 1041.
14. Fageras Bottcher M, Hmani-Aifa M, Lindstrom A et al.A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol 2004: 114: 561.
15. Yang IA, Barton SJ, Rorke S et al.Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun 2004: 5: 41.
16. Smit LA, Bongers SI, Ruven HJ et al.Atopy and new-onset asthma in young Danish farmers and CD14, TLR2, and TLR4 genetic polymorphisms: a nested case-control study. Clin Exp Allergy 2007: 37: 1602.
17. Asea A, Rehli M, Kabingu E et al.Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002: 277: 15028.
18. Li M, Carpio DF, Zheng Y et al.An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 2001: 166: 7128.
19. Van Why SK, Hildebranst F, Ardito T et al.Induction and intracellular localization of HSP-72 after renal ischemia. Am J Physiol 1992: 263: F769.
20. Padanilam BJ. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 2003: 284: F608.
21. Kariko K, Ni H, Capodici J et al.mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004: 279: 12542.
22. Racusen LC, Solez K, Colvin RB et al.The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
24. Tahara T, Arisawa T, Wang F et al.Toll-like receptor 2 -196 to 174del polymorphism influences the susceptibility of Japanese people to gastric Cancer. Cancer Sci 2007: 98: 1790.
25. Cheng PL, Eng HL, Chau MH, You HL, Lin TM. Genetic polymorphisms of viral infection associated with Toll like receptors in Chinese population. Transpl Res 2007: 150: 311.
26. Kruger B, Schröppel B, Ashkan R et al.A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol 2002: 13: 2585.
27. Kang SW, Park SJ, Kim YW et al.Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients. Int J Immunogenet 2008: 35: 25.
28. Manchanda PK, Mittal RD. Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantation. Mol Cell Biochem 2008: 311: 57.
29. Singh R, Kapoor R, Srivastava A, Mittal RD. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients. Scand J Immunol 2008: 69: 51.
30. Matzinger P. The danger model: a renewed sense of self. Science 2002: 296: 301.
31. Chowdhury P, Sacks SH, Sheerin NS. Toll-like receptors TLR 2 and TLR 4 initiate the innate immune response of the renal tubular epithelium to bacterial products. Clin Exp Immunol 2006: 145: 346.
32. Noguchi E, Nishimura F, Fukai H et al.An association study of asthma and total serum immunoglobulin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 2004: 34: 177.
33. Anders HJ, Banas B, Schlöndorff D. Signaling danger: toll-like receptors andtheir potential roles in kidney disease. J Am Soc Nephrol 2004: 15: 854.
34. Robson MG. Toll-like receptors and renal disease. Nephron Exp Nephrol 2009: 113: e1.
35. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappa B by Toll like receptor 3. Nature 2001: 413: 732.
36. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002: 168: 554.